MedPath

Norepinephrine Bitartrate

Norepinephrine Bitartrate 4 mg Added to 5% Dextrose 250 mL Bag

Approved
Approval ID

71f901b5-022b-43ea-b1a0-29adc9a1f718

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 6, 2015

Manufacturers
FDA

Cantrell Drug Company

DUNS: 035545763

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Norepinephrine Bitartrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code52533-165
Product Classification
G
Generic Name
Norepinephrine Bitartrate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMarch 6, 2015
FDA Product Classification

INGREDIENTS (7)

ANHYDROUS DEXTROSEInactive
Quantity: 50 mg in 1 mL
Code: 5SL0G7R0OK
Classification: IACT
Norepinephrine BitartrateActive
Quantity: 16 ug in 1 mL
Code: IFY5PE3ZRW
Classification: ACTIM
SODIUM CHLORIDEInactive
Quantity: 118.4 ug in 1 mL
Code: 451W47IQ8X
Classification: IACT
SODIUM METABISULFITEInactive
Quantity: 32 ug in 1 mL
Code: 4VON5FNS3C
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: CNTM
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: CNTM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Norepinephrine Bitartrate - FDA Drug Approval Details